Revvity, Inc. (NYSE:RVTY – Free Report) – KeyCorp dropped their FY2024 EPS estimates for Revvity in a report released on Monday, October 30th. KeyCorp analyst P. Knight now anticipates that the company will post earnings per share of $4.46 for the year, down from their prior forecast of $5.70. KeyCorp currently has a “Overweight” rating and a $110.00 price target on the stock. The consensus estimate for Revvity’s current full-year earnings is $4.54 per share. KeyCorp also issued estimates for Revvity’s FY2025 earnings at $5.30 EPS.
Several other equities research analysts have also issued reports on RVTY. JPMorgan Chase & Co. lowered their price target on shares of Revvity from $130.00 to $110.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 17th. Barclays dropped their price objective on shares of Revvity from $130.00 to $120.00 and set an “equal weight” rating for the company in a research note on Friday, September 29th. The Goldman Sachs Group decreased their price target on shares of Revvity from $120.00 to $105.00 and set a “buy” rating for the company in a research report on Tuesday. Sanford C. Bernstein started coverage on shares of Revvity in a research report on Thursday, September 28th. They issued an “outperform” rating and a $133.00 price target for the company. Finally, Robert W. Baird decreased their price objective on shares of Revvity from $165.00 to $147.00 and set an “outperform” rating for the company in a research report on Wednesday, August 2nd. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $118.71.
Revvity Trading Up 1.6 %
RVTY opened at $83.90 on Thursday. The company has a market cap of $10.42 billion, a PE ratio of 14.10 and a beta of 1.10. Revvity has a 12 month low of $79.50 and a 12 month high of $150.17. The company has a fifty day moving average of $106.85. The company has a quick ratio of 2.26, a current ratio of 2.01 and a debt-to-equity ratio of 0.41.
Revvity (NYSE:RVTY – Get Free Report) last released its earnings results on Monday, October 30th. The company reported $1.18 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.01). Revvity had a return on equity of 8.30% and a net margin of 26.90%. The business had revenue of $670.30 million for the quarter, compared to analyst estimates of $695.40 million. During the same period in the prior year, the firm posted $1.51 EPS. Revvity’s revenue was down 5.9% on a year-over-year basis.
Revvity Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Friday, January 19th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.33%. Revvity’s dividend payout ratio (DPR) is presently 4.71%.
Revvity, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
- Five stocks we like better than Revvity
- The Most Important Warren Buffett Stock for Investors: His Own
- A bullish storm is brewing for cloud stocks
- How to Invest in Fertilizer
- Is Extreme Networks’ forecast a sign of industry woes?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Profits come after ignorance Is highest: A PayPal story
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.